Compare PALI & AVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PALI | AVBC |
|---|---|---|
| Founded | 1996 | 1869 |
| Country | United States | United States |
| Employees | 14 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.0M | 408.0M |
| IPO Year | 2019 | 2025 |
| Metric | PALI | AVBC |
|---|---|---|
| Price | $2.06 | $21.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $11.29 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 1.7M | 155.1K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $30.59 |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $14.31 |
| 52 Week High | $2.86 | $22.90 |
| Indicator | PALI | AVBC |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 48.37 |
| Support Level | $1.93 | $21.64 |
| Resistance Level | $2.17 | $22.69 |
| Average True Range (ATR) | 0.10 | 0.43 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 37.50 | 18.78 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Avidia Bancorp Inc business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial and industrial loans, one-to four-family residential mortgage loans, and commercial real estate loans.